Search research articles
Contact Us
Filters
Showing results (771-780 of 924) with videos related to
Page
of 93
Sort By:
Pain
|
July 6, 2002
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy
Julie E Hammack, John C Michalak, Charles L Loprinzi, et al.
Gynecologic Oncology
|
April 26, 2011
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma
S John Weroha, Ann L Oberg, Katie L Allen Ziegler, et al.
Molecular Psychiatry
|
March 10, 2022
Schizophrenia: a disorder of broken brain bioenergetics
Nicholas D Henkel, Xiajoun Wu, Sinead M O'Donovan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 12, 2010
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial
Lisa A Kottschade, Jeff A Sloan, Miroslaw A Mazurczak, et al.
Neurobiology of Aging
|
November 4, 2018
Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla
Georg Oeltzschner, S Andrea Wijtenburg, Mark Mikkelsen, et al.
European Journal of Immunology
|
November 28, 2013
IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function
Mermagya Dhakal, John C Hardaway, Fatma Betul Guloglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Transdermal clonidine for ameliorating tamoxifen-induced hot flashes
R M Goldberg, C L Loprinzi, J R O'Fallon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2009
Endpoints in phase II trials for advanced non-small cell lung cancer
Sumithra J Mandrekar, Yingwei Qi, Shauna L Hillman, et al.
Schizophrenia Bulletin
|
February 24, 2022
Relating Glutamate, Conditioned, and Clinical Hallucinations via 1H-MR Spectroscopy
Pantelis Leptourgos, Sonia Bansal, Jenna Dutterer, et al.
Cancer
|
March 11, 2003
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma
Aminah Jatoi, Neil Ellison, Patrick A Burch, et al.
Page
of 93
Search research articles
Search
Showing results (771-780 of 924) with videos related to
Sort By:
Page
of 93
Pain
|
July 6, 2002
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy
Julie E Hammack, John C Michalak, Charles L Loprinzi, et al.
Gynecologic Oncology
|
April 26, 2011
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma
S John Weroha, Ann L Oberg, Katie L Allen Ziegler, et al.
Molecular Psychiatry
|
March 10, 2022
Schizophrenia: a disorder of broken brain bioenergetics
Nicholas D Henkel, Xiajoun Wu, Sinead M O'Donovan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 12, 2010
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial
Lisa A Kottschade, Jeff A Sloan, Miroslaw A Mazurczak, et al.
Neurobiology of Aging
|
November 4, 2018
Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla
Georg Oeltzschner, S Andrea Wijtenburg, Mark Mikkelsen, et al.
European Journal of Immunology
|
November 28, 2013
IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function
Mermagya Dhakal, John C Hardaway, Fatma Betul Guloglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Transdermal clonidine for ameliorating tamoxifen-induced hot flashes
R M Goldberg, C L Loprinzi, J R O'Fallon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2009
Endpoints in phase II trials for advanced non-small cell lung cancer
Sumithra J Mandrekar, Yingwei Qi, Shauna L Hillman, et al.
Schizophrenia Bulletin
|
February 24, 2022
Relating Glutamate, Conditioned, and Clinical Hallucinations via 1H-MR Spectroscopy
Pantelis Leptourgos, Sonia Bansal, Jenna Dutterer, et al.
Cancer
|
March 11, 2003
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma
Aminah Jatoi, Neil Ellison, Patrick A Burch, et al.
Page
of 93